scholarly article | Q13442814 |
P50 | author | Ruslan Medzhitov | Q517459 |
P2093 | author name string | Shuang Yu | |
Dominik D Schenten | |||
Esther Florsheim | |||
Noah W Palm | |||
Rachel K Rosenstein | |||
P2860 | cites work | IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 |
Development and function of group 2 innate lymphoid cells | Q26862916 | ||
Insights into the initiation of type 2 immune responses | Q26865705 | ||
Approaching the asymptote? Evolution and revolution in immunology | Q28274344 | ||
The function of allergy: immunological defense against toxins | Q28284387 | ||
IL-33, a potent inducer of adaptive immunity to intestinal nematodes | Q28505946 | ||
Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene | Q28588495 | ||
Molecular mechanisms of necroptosis: an ordered cellular explosion | Q29616004 | ||
Immunological and inflammatory functions of the interleukin-1 family | Q29619669 | ||
New paradigms in type 2 immunity | Q33835435 | ||
Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. | Q33904042 | ||
A mechanism for the initiation of allergen-induced T helper type 2 responses | Q34010133 | ||
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance | Q34035754 | ||
RETRACTED: Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. | Q34085160 | ||
Systemic immediate allergic reactions to arthropod stings and bites | Q34396469 | ||
Mast cells can enhance resistance to snake and honeybee venoms | Q34551900 | ||
Bee and wasp venoms | Q34696260 | ||
Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice | Q35370039 | ||
Interleukin 33 as a mechanically responsive cytokine secreted by living cells | Q35838985 | ||
Proteases in helminth- and allergen- induced inflammatory responses | Q36279678 | ||
Participation of MyD88 and interleukin-33 as innate drivers of Th2 immunity to Trichinella spiralis | Q36804679 | ||
Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine | Q36974519 | ||
The molecular basis of allergenicity. | Q37308451 | ||
Phospholipase A2 structure/function, mechanism, and signaling | Q37326136 | ||
Pattern recognition receptors and control of adaptive immunity | Q37361471 | ||
The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms | Q37565656 | ||
New insights into innate immune mechanisms underlying allergenicity | Q37662191 | ||
The enigmatic processing and secretion of interleukin-33. | Q37715704 | ||
Insect venoms | Q37762375 | ||
Mechanisms of immunotherapy to wasp and bee venom | Q37897667 | ||
IL-33: a Janus cytokine | Q37998317 | ||
Allergy to insect stings. II. Phospholipase A: the major allergen in honeybee venom | Q39360873 | ||
Venoms, antivenoms and immunotherapy | Q40851422 | ||
Allergic host defences | Q41190858 | ||
Melittin and phospholipase A2 from bee (Apis mellifera) venom cause necrosis of murine skeletal muscle in vivo | Q42529079 | ||
T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses | Q42944108 | ||
Basophils express a type 2 cytokine profile on exposure to proteases from helminths and house dust mites | Q44276703 | ||
Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter | Q46062240 | ||
The significance of the mast cell response to bee venom | Q52500091 | ||
Immunity of bee keepers to some constituents of bee venom: phospholipase-A antibodies. | Q52625336 | ||
Mast cells and local resistance to Russell's viper venom | Q69980076 | ||
A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2 | Q71707099 | ||
IL-33-activated dendritic cells are critical for allergic airway inflammation | Q83790505 | ||
Characterization of allergens in four South American snake species | Q83991552 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | venom | Q3386847 |
P304 | page(s) | 976-985 | |
P577 | publication date | 2013-10-24 | |
P1433 | published in | Immunity | Q6005457 |
P1476 | title | Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity | |
P478 | volume | 39 |
Q38241536 | A Question of Nature: Some Antigens are Bound to be Allergens |
Q35289292 | A single glycan on IgE is indispensable for initiation of anaphylaxis. |
Q37611447 | A tissue checkpoint regulates type 2 immunity. |
Q33581103 | Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa |
Q38239279 | Antibodies as natural adjuvants. |
Q52762094 | Antibodies: taking the sting out. |
Q39265436 | Are Mast Cells MASTers in Cancer? |
Q33857994 | Are ticks venomous animals? |
Q46253139 | B Cell Intrinsic Mechanisms Constraining IgE Memory. |
Q34372070 | B cells regulate CD4+ T cell responses to papain following B cell receptor-independent papain uptake |
Q45974348 | Bee Venom Phospholipase A2, a Novel Foxp3+ Regulatory T Cell Inducer, Protects Dopaminergic Neurons by Modulating Neuroinflammatory Responses in a Mouse Model of Parkinson's Disease. |
Q26767063 | Bee Venom Phospholipase A2: Yesterday's Enemy Becomes Today's Friend |
Q35493627 | Bee venom phospholipase A2 protects against acetaminophen-induced acute liver injury by modulating regulatory T cells and IL-10 in mice |
Q36410600 | Bee venom phospholipase A2 suppresses allergic airway inflammation in an ovalbumin-induced asthma model through the induction of regulatory T cells |
Q26865509 | Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer |
Q41727136 | Cancer research meets tick vectors for infectious diseases |
Q55012882 | Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy. |
Q42494705 | Controversial role of mast cells in skin cancers |
Q64071386 | Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A Against MPTP-Induced Parkinson's Disease in Mice |
Q36414954 | Endogenous secreted phospholipase A2 group X regulates cysteinyl leukotrienes synthesis by human eosinophils. |
Q36264141 | Enhanced transcriptomic responses in the Pacific salmon louse Lepeophtheirus salmonis oncorhynchi to the non-native Atlantic Salmon Salmo salar suggests increased parasite fitness |
Q52725595 | Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. |
Q58045445 | Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response |
Q36983081 | Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases |
Q90566186 | Frontline Science: RIP2 promotes house dust mite-induced allergic airway inflammation |
Q90357108 | Function of secreted phospholipase A2 group-X in asthma and allergic disease |
Q91772545 | Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care |
Q33559067 | GM-CSF produced by the airway epithelium is required for sensitization to cockroach allergen |
Q38229984 | Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. |
Q34257404 | Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection |
Q40467026 | IL-1R1-MyD88 axis elicits papain-induced lung inflammation. |
Q35832890 | IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes. |
Q33992276 | IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure |
Q88125512 | IL-33 meets allergens at the gate |
Q40603304 | Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma |
Q92027568 | IgE Glycosylation in Health and Disease |
Q38844328 | IgE and mast cells in host defense against parasites and venoms |
Q36469735 | IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity. |
Q36025549 | IgE/FcεRI-Mediated Antigen Cross-Presentation by Dendritic Cells Enhances Anti-Tumor Immune Responses |
Q38994739 | Immunoglobulin Glycosylation Effects in Allergy and Immunity |
Q38797790 | Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora |
Q47285890 | Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. |
Q47117344 | Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria |
Q41112447 | Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms |
Q26775969 | Mast cells and IgE in defense against venoms: Possible "good side" of allergy? |
Q99419174 | Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts |
Q89947583 | Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response |
Q64963613 | Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases. |
Q36539857 | Potential effector and immunoregulatory functions of mast cells in mucosal immunity |
Q37378862 | Protective Effects of Intratracheally-Administered Bee Venom Phospholipase A2 on Ovalbumin-Induced Allergic Asthma in Mice. |
Q36946923 | Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice. |
Q27027694 | Regulatory constraints in the generation and differentiation of IgE-expressing B cells |
Q57069225 | Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44 |
Q47334197 | Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen |
Q35139991 | Skin exposure promotes a Th2-dependent sensitization to peanut allergens |
Q41367020 | Stingray venom activates IL-33 producing cardiomyocytes, but not mast cell, to promote acute neutrophil-mediated injury |
Q28085379 | Testing the 'toxin hypothesis of allergy': mast cells, IgE, and innate and acquired immune responses to venoms |
Q35828990 | The Extracellular Domains of IgG1 and T Cell-Derived IL-4/IL-13 Are Critical for the Polyclonal Memory IgE Response In Vivo |
Q36509214 | The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis |
Q35994584 | The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease |
Q39181842 | The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals |
Q38987762 | The Roles of the Secreted Phospholipase A2 Gene Family in Immunology |
Q58695426 | The allergic response mediated by fire ant venom proteins |
Q64988741 | The functional biology of peanut allergens and possible links to their allergenicity. |
Q34391415 | The interleukin-1 family: back to the future |
Q47810222 | The pathophysiology of anaphylaxis |
Q52608299 | The role of extracellular vesicles when innate meets adaptive. |
Q38224933 | The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells. |
Q35894698 | Therapeutic Effects of Bee Venom on Immunological and Neurological Diseases |
Q35079476 | Type II cytokines impair host defense against an intracellular fungal pathogen by amplifying macrophage generation of IL-33. |
Q56984099 | Une réponse allergique pour lutter contre les venins |
Q38491546 | What makes an allergen? |
Q42957096 | Why do we study animal toxins? |